Tonix Pharmaceuticals Holding (TNXP) Other Operating Expenses (2019 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Other Operating Expenses of $1.6 million for Q1 2026, up 67.34% year-over-year from $943000.0 in Q1 2025, and up 49.15% quarter-over-quarter from $1.1 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Other Operating Expenses (2019 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Other Operating Expenses history runs 5 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 67.34% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $7.3 million (down 88.98% YoY), while the FY2025 annual figure was $6.6 million, down 90.05% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $1.6 million, up from $1.1 million in the prior quarter.
- The five-year high for Other Operating Expenses was $62.3 million in Q2 2024, with the low at $943000.0 in Q1 2025.
- The 4-year median for Other Operating Expenses is $1.6 million (2026), against an average of $7.2 million.
- The sharpest annual moves came in 2025 and 2026: Other Operating Expenses plunged 94.75% in 2025, then surged 67.34% in 2026.
- Tonix Pharmaceuticals Holding's Other Operating Expenses stood at $2.4 million in 2023, then plunged by 50.02% to $1.2 million in 2024, then slipped by 10.57% to $1.1 million in 2025, then surged by 49.15% to $1.6 million in 2026.
- Business Quant data shows TNXP's Other Operating Expenses at $1.6 million in Q1 2026, $1.1 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 703,000.00 |
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 3.27 Mn |
| Mar 31, 2025 | 943,000.00 |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 62.32 Mn |
| Mar 31, 2024 | 1.66 Mn |
| Dec 31, 2023 | 2.37 Mn |
| Sep 30, 2023 | 2.37 Mn |
| Dec 31, 2019 | 5.69 Mn |